Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol results in increased expression of MAPT protein modified form | increases expression | 20157255
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol results in increased phosphorylation of MAPT protein | increases phosphorylation | 20157255
|
C076996 |
27-hydroxycholesterol |
LEP protein inhibits the reaction [27-hydroxycholesterol results in increased expression of MAPT protein modified form] | decreases reaction|increases expression | 20157255
|
C076996 |
27-hydroxycholesterol |
LEP protein inhibits the reaction [27-hydroxycholesterol results in increased phosphorylation of MAPT protein] | decreases reaction|increases phosphorylation | 20157255
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of MAPT mRNA | affects expression | 17562736
|
D000171 |
Acrolein |
Acrolein results in increased phosphorylation of MAPT protein | increases phosphorylation | 12605413
|
D000171 |
Acrolein |
Lithium inhibits the reaction [Acrolein results in increased phosphorylation of MAPT protein] | decreases reaction|increases phosphorylation | 12605413
|
D000171 |
Acrolein |
SB 203580 inhibits the reaction [Acrolein results in increased phosphorylation of MAPT protein] | decreases reaction|increases phosphorylation | 12605413
|
D000171 |
Acrolein |
Acrolein promotes the reaction [MAPT protein binds to MAPT protein] | affects binding|increases reaction | 17082178
|
D000171 |
Acrolein |
Acrolein results in increased phosphorylation of MAPT protein | increases phosphorylation | 12605413
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of MAPT protein | affects expression | 20106945
|
D015766 |
Albendazole |
Albendazole results in decreased expression of MAPT mRNA | decreases expression | 16930453
|
D015766 |
Albendazole |
Albendazole results in decreased expression of MAPT protein | decreases expression | 16930453
|
C001570 |
alexidine |
alexidine results in decreased expression of MAPT protein | decreases expression | 16930453
|
D043582 |
5-alpha-Dihydroprogesterone |
5-alpha-Dihydroprogesterone results in decreased expression of MAPT protein | decreases expression | 17443805
|
D043582 |
5-alpha-Dihydroprogesterone |
5-alpha-Dihydroprogesterone results in increased phosphorylation of MAPT protein | increases phosphorylation | 17443805
|
D000535 |
Aluminum |
Aluminum results in increased phosphorylation of MAPT protein | increases phosphorylation | 17662457
|
C041524 |
aluminum sulfate |
aluminum sulfate results in increased phosphorylation of MAPT protein | increases phosphorylation | 11388372
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MAPT mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of MAPT protein modified form | decreases expression | 16483693
|
D016718 |
Arachidonic Acid |
Arachidonic Acid results in increased phosphorylation of MAPT protein | increases phosphorylation | 12605413
|
D016718 |
Arachidonic Acid |
Ro 31-8220 inhibits the reaction [Arachidonic Acid results in increased phosphorylation of MAPT protein] | decreases reaction|increases phosphorylation | 12605413
|
D001151 |
Arsenic |
Arsenic metabolite affects the expression of MAPT mRNA | affects expression | 17553662
|
D016589 |
Astemizole |
Astemizole binds to MAPT protein alternative form | affects binding | 20110603
|
D001374 |
Azacitidine |
Azacitidine results in decreased expression of MAPT protein | decreases expression | 16930453
|
D001375 |
Azaguanine |
Azaguanine results in decreased expression of MAPT protein | decreases expression | 16930453
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MAPT mRNA | affects cotreatment|increases expression | 18164116
|
C004532 |
benzoquinone |
benzoquinone promotes the reaction [MAPT protein binds to MAPT protein] | affects binding|increases reaction | 16180106
|
D002166 |
Camptothecin |
Camptothecin results in decreased expression of MAPT mRNA | decreases expression | 16930453
|
D002166 |
Camptothecin |
Camptothecin results in decreased expression of MAPT protein | decreases expression | 16930453
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of MAPT mRNA | affects expression | 17484886
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of MAPT mRNA | decreases expression | 16644059
|
C062047 |
chelidonine |
chelidonine results in decreased expression of MAPT protein | decreases expression | 16930453
|
C011585 |
ciclopirox |
ciclopirox results in decreased expression of MAPT protein | decreases expression | 16930453
|
D003078 |
Colchicine |
Colchicine results in decreased expression of MAPT protein | decreases expression | 16930453
|
D003520 |
Cyclophosphamide |
MAPT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MAPT mRNA | decreases expression | 20106945
|
C017160 |
cypermethrin |
[Okadaic Acid co-treated with cypermethrin] results in increased phosphorylation of MAPT protein | affects cotreatment|increases phosphorylation | 7723735
|
D003630 |
Daunorubicin |
Daunorubicin results in decreased expression of MAPT mRNA | decreases expression | 16930453
|
D003630 |
Daunorubicin |
Daunorubicin results in decreased expression of MAPT protein | decreases expression | 16930453
|
C029108 |
diaziquone |
diaziquone results in decreased expression of MAPT protein | decreases expression | 16930453
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MAPT mRNA | affects cotreatment|increases expression | 18164116
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of and results in increased phosphorylation of MAPT protein | increases expression|increases phosphorylation | 20387270 19542621
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in decreased expression of MAPT mRNA | decreases expression | 17005392
|
D004298 |
Dopamine |
Dopamine metabolite promotes the reaction [MAPT protein binds to MAPT protein] | affects binding|increases reaction | 16180106
|
D004298 |
Dopamine |
Dopamine promotes the reaction [MAPT protein binds to MAPT protein] | affects binding|increases reaction | 16180106
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of MAPT protein | decreases expression | 16930453
|
D004317 |
Doxorubicin |
MAPT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D004640 |
Emetine |
Emetine results in decreased expression of MAPT protein | decreases expression | 16930453
|
D004642 |
Emodin |
Emodin results in decreased expression of MAPT mRNA | decreases expression | 16045814
|
D004958 |
Estradiol |
Estradiol results in increased expression of MAPT protein | increases expression | 20579400
|
D004958 |
Estradiol |
Tamoxifen inhibits the reaction [Estradiol results in increased expression of MAPT protein] | decreases reaction|increases expression | 20579400
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of MAPT mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of MAPT mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAPT mRNA | affects cotreatment|increases expression | 17942748
|
D005273 |
Fenbendazole |
Fenbendazole results in decreased expression of MAPT protein | decreases expression | 16930453
|
D005472 |
Fluorouracil |
MAPT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of MAPT protein | decreases expression | 20579400
|
D006037 |
Glyoxal |
Glyoxal promotes the reaction [MAPT protein binds to MAPT protein] | affects binding|increases reaction | 17082178
|
D006096 |
Gramicidin |
Gramicidin results in decreased expression of MAPT protein | decreases expression | 16930453
|
D017313 |
Fenretinide |
Fenretinide results in increased expression of MAPT mRNA | increases expression | 16570282
|
C058028 |
immunomycin |
[Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein | affects cotreatment|increases phosphorylation | 7723735
|
C058028 |
immunomycin |
[Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein | affects cotreatment|increases phosphorylation | 7723735
|
C058028 |
immunomycin |
[Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein | affects cotreatment|increases phosphorylation | 7723735
|
D015759 |
Ionomycin |
Ionomycin results in decreased phosphorylation of MAPT protein | decreases phosphorylation | 9200503
|
D015759 |
Ionomycin |
Okadaic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of MAPT protein] | decreases phosphorylation|decreases reaction | 9200503
|
D015759 |
Ionomycin |
Ionomycin results in decreased phosphorylation of MAPT protein | decreases phosphorylation | 9200503
|
D015759 |
Ionomycin |
Okadaic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of MAPT protein] | decreases phosphorylation|decreases reaction | 9200503
|
C058687 |
lansoprazole |
lansoprazole binds to MAPT protein alternative form | affects binding | 20110603
|
D007832 |
Lasalocid |
Lasalocid results in decreased expression of MAPT protein | decreases expression | 16930453
|
D008094 |
Lithium |
Lithium inhibits the reaction [Acrolein results in increased phosphorylation of MAPT protein] | decreases reaction|increases phosphorylation | 12605413
|
D008315 |
Malondialdehyde |
Malondialdehyde promotes the reaction [MAPT protein binds to MAPT protein] | affects binding|increases reaction | 17082178
|
D008463 |
Mebendazole |
Mebendazole results in decreased expression of MAPT protein | decreases expression | 16930453
|
D008751 |
Methylene Blue |
Methylene Blue results in decreased expression of MAPT protein | decreases expression | 16930453
|
D008751 |
Methylene Blue |
Methylene Blue results in increased expression of MAPT mRNA | increases expression | 16930453
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased expression of MAPT mRNA | decreases expression | 12517777
|
D009020 |
Morphine |
Morphine results in increased expression of MAPT mRNA | increases expression | 15183518
|
D009173 |
Mycophenolic Acid |
Mycophenolic Acid results in decreased expression of MAPT protein | decreases expression | 16930453
|
C029938 |
nickel sulfate |
nickel sulfate results in decreased expression of MAPT mRNA | decreases expression | 16100012
|
D015739 |
Nocodazole |
Nocodazole results in decreased expression of MAPT protein | decreases expression | 16930453
|
D009640 |
Norethindrone |
Norethindrone results in decreased expression of MAPT protein | decreases expression | 16930453
|
D019319 |
Okadaic Acid |
[Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein | affects cotreatment|increases phosphorylation | 7723735
|
D019319 |
Okadaic Acid |
Okadaic Acid results in increased phosphorylation of MAPT protein | increases phosphorylation | 7723735
|
D019319 |
Okadaic Acid |
[Okadaic Acid co-treated with cypermethrin] results in increased phosphorylation of MAPT protein | affects cotreatment|increases phosphorylation | 7723735
|
D019319 |
Okadaic Acid |
[Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein | affects cotreatment|increases phosphorylation | 7723735
|
D019319 |
Okadaic Acid |
Okadaic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of MAPT protein] | decreases phosphorylation|decreases reaction | 9200503
|
D019319 |
Okadaic Acid |
[Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein | affects cotreatment|increases phosphorylation | 7723735
|
D019319 |
Okadaic Acid |
Okadaic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of MAPT protein] | decreases phosphorylation|decreases reaction | 9200503
|
D019319 |
Okadaic Acid |
Okadaic Acid inhibits the reaction [Potassium Chloride results in decreased phosphorylation of MAPT protein] | decreases phosphorylation|decreases reaction | 9200503
|
D019319 |
Okadaic Acid |
Okadaic Acid results in increased phosphorylation of MAPT protein | increases phosphorylation | 7723735
|
D010126 |
Ozone |
Ozone results in decreased expression of MAPT mRNA | decreases expression | 12763052
|
D017239 |
Paclitaxel |
MAPT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D017239 |
Paclitaxel |
Paclitaxel results in decreased expression of MAPT mRNA | decreases expression | 16930453
|
D017239 |
Paclitaxel |
Paclitaxel results in decreased expression of MAPT protein | decreases expression | 16930453
|
D011034 |
Podophyllotoxin |
Podophyllotoxin results in decreased expression of MAPT protein | decreases expression | 16930453
|
D011189 |
Potassium Chloride |
Okadaic Acid inhibits the reaction [Potassium Chloride results in decreased phosphorylation of MAPT protein] | decreases phosphorylation|decreases reaction | 9200503
|
D011189 |
Potassium Chloride |
Potassium Chloride results in decreased phosphorylation of MAPT protein | decreases phosphorylation | 9200503
|
D011280 |
Pregnanolone |
Pregnanolone results in decreased expression of MAPT protein | decreases expression | 17443805
|
D011280 |
Pregnanolone |
Pregnanolone results in increased phosphorylation of MAPT protein | increases phosphorylation | 17443805
|
D011374 |
Progesterone |
Progesterone results in decreased expression of MAPT protein | decreases expression | 17443805
|
D011374 |
Progesterone |
Progesterone results in increased phosphorylation of MAPT protein | increases phosphorylation | 17443805
|
C008704 |
pyrithione |
GSK3B protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of MAPT protein] | affects cotreatment|increases phosphorylation|increases reaction | 17098228
|
C008704 |
pyrithione |
[Zinc co-treated with pyrithione] results in increased phosphorylation of MAPT protein | affects cotreatment|increases phosphorylation | 17098228
|
D011765 |
Pyruvaldehyde |
Pyruvaldehyde promotes the reaction [MAPT protein binds to MAPT protein] | affects binding|increases reaction | 17082178
|
C059514 |
resveratrol |
resveratrol results in decreased expression of MAPT mRNA | decreases expression | 12569576
|
C064758 |
Ro 31-8220 |
Ro 31-8220 inhibits the reaction [Arachidonic Acid results in increased phosphorylation of MAPT protein] | decreases reaction|increases phosphorylation | 12605413
|
D012402 |
Rotenone |
Rotenone results in decreased expression of MAPT protein | decreases expression | 16930453
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [Acrolein results in increased phosphorylation of MAPT protein] | decreases reaction|increases phosphorylation | 12605413
|
D017632 |
Asbestos, Serpentine |
Asbestos, Serpentine results in decreased expression of MAPT mRNA | decreases expression | 16251409
|
D013629 |
Tamoxifen |
Tamoxifen inhibits the reaction [Estradiol results in increased expression of MAPT protein] | decreases reaction|increases expression | 20579400
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of MAPT protein | increases expression | 20579400
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of MAPT mRNA | affects expression | 17555576
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of MAPT mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MAPT mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAPT mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MAPT mRNA | increases expression | 16922920 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased phosphorylation of MAPT protein | increases phosphorylation | 18996433
|
D014212 |
Tretinoin |
MAPT protein affects the susceptibility to Tretinoin | affects response to substance | 16417947
|
D014212 |
Tretinoin |
MAPT protein promotes the reaction [Tretinoin affects the localization of MAPT protein] | affects localization|increases reaction | 16417947
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [MAPT protein affects the localization of [MAPT protein binds to RARG protein]] | affects binding|affects localization|increases reaction | 16417947
|
D014212 |
Tretinoin |
MAPT protein promotes the reaction [Tretinoin results in increased activity of CASP3 protein] | increases activity|increases reaction | 16417947
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of MAPT protein | increases expression | 17130476
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of MAPT mRNA | increases expression | 19101580
|
D015032 |
Zinc |
GSK3B protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of MAPT protein] | affects cotreatment|increases phosphorylation|increases reaction | 17098228
|
D015032 |
Zinc |
[Zinc co-treated with pyrithione] results in increased phosphorylation of MAPT protein | affects cotreatment|increases phosphorylation | 17098228
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.81 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
5.93 | 14514962 11752688 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
5.93 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.27 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.84 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.20 | 17505938 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
4.67 | 17202136 17190629 16889938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.21 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
7.50 | 21297076 20525806 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
7.50 | 12718980 11954676 16100012 19131640 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
10.82 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
10.82 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
10.82 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
10.82 | 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
10.82 | 17638652 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
8.56 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
8.56 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
resveratrol |
8.56 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
7.65 | 17620307 16434500 19061943 18056438 17162532 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
7.65 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
4.47 | 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
cypermethrin |
4.22 | 16487989 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.85 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.02 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
marker/mechanism |
|
| 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
27-hydroxycholesterol |
15.74 | 14523054 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
15.74 | 14715435 17570602 15207723 |
MESH:D000544 |
Alzheimer Disease |
|
Aluminum |
15.74 | 10721010 17662457 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
15.74 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
15.74 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
15.74 | 16162502 16183991 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
15.74 | 16580781 16325427 16410023 17119284 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.49 | 17688650 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.79 | 15469931 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
11.36 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Malondialdehyde |
11.36 | 17278206 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
11.36 | 11748828 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.21 | 16916123 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
9.57 | 10982225 |
MESH:D000799 |
Angioedema |
|
Astemizole |
9.57 | 2883202 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
2.98 | 17497229 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.61 | 18414634 12569548 16835338 16251483 |
MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
13.13 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
13.13 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
13.13 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
9.41 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
9.41 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
9.41 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
3.87 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
3.87 | 16292516 |
MESH:D001195 |
Asbestosis |
|
Asbestos, Serpentine |
4.97 | 10751356 |
MESH:D001249 |
Asthma |
|
Ozone |
6.27 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Tretinoin |
6.27 | 16456186 |
MESH:D001249 |
Asthma |
|
Zinc |
6.27 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
27-hydroxycholesterol |
11.85 | 11166758 9059518 |
MESH:D050197 |
Atherosclerosis |
|
Acrolein |
11.85 | 16037261 17363696 16126721 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
11.85 | 19371607 12928151 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
11.85 | 17967414 16873680 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.16 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.07 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
2.07 | 18582451 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.07 | 19460635 18316065 18775368 18985861 17688650 18558336 18396377 20603192 18940202 17507914 16609825 15238991 17157402 18177632 19232924 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.71 | 16935849 |
MESH:D001528 |
Behcet Syndrome |
|
Colchicine |
5.40 | 15870978 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
6.19 | 20046352 20338123 19153942 17594078 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
6.19 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
6.76 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
6.76 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.05 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
6.33 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
6.33 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
3.96 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
3.89 | 15867366 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.60 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Pregnanolone |
14.60 | 15665606 15380490 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
14.60 | 15380490 15665606 15845082 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
14.60 | 17109824 |
MESH:D002545 |
Brain Ischemia |
|
Morphine |
8.22 | 19211983 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
8.22 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
7.00 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
7.00 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
10.68 | 17020986 17388661 12006526 18234424 18323546 11325840 15093573 15136595 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
10.68 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
10.68 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
10.68 | 18382427 18695136 18628466 19526202 15668708 15939500 17369602 16264153 15993339 16096432 16826403 16935488 16595493 15136595 15692762 17426702 18234424 15567936 16322301 16115903 11325840 15634643 17983394 15994142 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
10.68 | 12948864 19861407 17289903 17261762 14630087 18497071 16675129 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
10.68 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
10.68 | 16110121 19217205 16595493 15136595 16557594 18608205 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
10.68 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
10.68 | 18223236 16115903 18323546 11325840 16244791 15136595 16273361 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
10.68 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
10.68 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
10.68 | 18984771 19155303 19200415 19142967 16273361 19115204 17440819 19221464 20859285 20135344 21152245 18855134 18997820 16202921 19288272 18815881 19059307 19189210 19066611 11161223 21138602 20390343 18425577 20544844 20065188 19084267 20005174 17893378 19410462 19189212 19289846 18629630 19103187 15565566 18821012 15668708 19487384 19011961 18351453 16818667 17049068 16873071 17261762 19244106 17242785 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
10.68 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
10.68 | 16873071 16443354 16166294 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.09 | 17626835 18315731 16777450 15516495 19059883 18417511 14754758 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.86 | 16813970 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.01 | 16183385 |
MESH:D002177 |
Candidiasis |
|
ciclopirox |
6.36 | 16640825 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.74 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.07 | 16227642 3786805 15700767 16124888 15673190 16097048 15721981 16192424 16050911 16011737 18705752 10355542 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
9.89 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
9.89 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
6.22 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.22 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.13 | 17687452 15504454 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.79 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.42 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
33.78 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
33.78 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
33.78 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
33.78 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
33.78 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
33.78 | 17173139 10737359 17978847 16681979 18788625 16807293 20214788 19107877 19052882 19383236 16878318 18785209 16288022 17162532 20514400 20101231 16569478 20007298 17761372 20935162 18506893 17428255 20727157 18056438 16935385 18691550 3581430 18978308 19539802 16830150 16328049 18494052 17138121 11831363 19919837 19394651 16502159 20432363 3084413 20084675 19171122 18971187 19701751 19208518 18210153 16698587 18393292 19418558 19335982 20524982 17055752 19519916 10672840 16540662 21159647 20512989 19822196 18665156 16779866 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
33.78 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
33.78 | 16234567 18059187 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
33.78 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
33.78 | 17159502 16270382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
33.78 | 16332177 16799960 17045692 17088986 18930000 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
33.78 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
33.78 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
33.78 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
33.78 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
9.08 | 16152834 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
9.08 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
8.55 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
8.55 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
8.55 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
17.62 | 17687452 18922899 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
17.62 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
17.62 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
17.62 | 16757204 16280240 18986760 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
17.62 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
17.62 | 16051514 16096774 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
17.62 | 16543248 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
7.37 | 18640142 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
7.37 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
1.92 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.02 | 16651473 17382496 16269455 16952015 18627295 16278810 17308081 16612575 17351982 17974986 17329180 17007740 17928571 17924179 15476868 15811867 16109756 15792986 15505089 16242529 16731534 17519947 16364871 16455267 17131338 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.64 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
9.20 | 15738583 19152805 17938729 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
9.20 | 15458977 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
9.20 | 16936243 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
3.68 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
5.64 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
5.64 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
8.07 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
8.07 | 17174075 21159647 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
8.07 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
10.56 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
10.56 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.39 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.25 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.25 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
5.90 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
5.90 | 16105132 15861022 17681005 17333356 16919318 17110522 11677210 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.42 | 16461808 |
MESH:D016770 |
Ciliophora Infections |
|
Albendazole |
5.34 | 12113305 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.53 | 8697196 15668235 15340226 12621046 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.53 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
7.28 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
7.28 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.28 | 17725105 16510598 17172411 15001691 17016597 17018589 17287894 18772588 16340194 17169374 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.28 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
8.73 | 17597105 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
8.73 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
8.73 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
8.73 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
8.73 | 15148649 17094418 16303861 18448328 16331619 16391804 15289873 20501625 17454858 18288408 18509181 18949393 17695437 17255274 18383874 17594712 17401013 17016601 16524972 14970324 18802399 16282729 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
8.73 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
8.73 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.44 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.25 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.42 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.42 | 9211117 17551590 8800419 9142499 9224671 10589399 14991402 16925845 9664655 9125849 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
4.42 | 8888407 16575769 17688650 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
4.42 | 19302082 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
3.86 | 12952375 16002989 |
MESH:D003556 |
Cystitis |
|
Acrolein |
9.63 | 12161096 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
9.63 | 18433785 18295254 10498854 16651033 15276878 17979934 12913760 10700343 18372110 12161096 15643279 18483878 16614059 18710439 12388444 16989017 18093676 17010015 16413132 11948286 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
10.80 | 16733453 |
MESH:D007644 |
Darier Disease |
|
Lithium |
10.80 | 20338123 |
MESH:D003704 |
Dementia |
marker/mechanism |
|
| |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.65 | 19031437 |
MESH:D003715 |
Dengue |
|
27-hydroxycholesterol |
4.96 | 19427377 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
3.02 | 16823706 11298694 16780908 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.03 | 19244398 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
3.58 | 16479319 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
6.67 | 15331540 10990075 11751995 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
6.67 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
2.94 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
3.41 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.41 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
11.42 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
11.42 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
11.42 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Pregnanolone |
10.09 | 17187935 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
10.09 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Morphine |
3.85 | 2540324 |
MESH:D004244 |
Dizziness |
|
Astemizole |
5.72 | 3105558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.49 | 11529661 18713872 17522070 11743745 17906064 16081117 16781746 15619225 14725611 17562736 19739265 19085960 12705907 19164858 10663392 19370779 12958197 16177239 10915739 12392966 15968718 19923254 11287661 16393943 19416960 11739529 18071297 2444490 11461765 12594235 11421492 12153990 16109766 10774834 11834606 19420014 16227642 14550746 14986274 12540782 16485898 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
11.49 | 10915739 6623471 17522070 3786805 19085960 19336974 15968718 15027814 16177239 3732212 4309450 15998439 2869522 7120509 9327722 11566570 21278145 10092053 16227642 6884620 7440962 7179309 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
11.49 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
11.49 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.49 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
11.49 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.36 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
6.23 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
6.23 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
lansoprazole |
4.92 | 17151854 |
MESH:D004417 |
Dyspnea |
|
cypermethrin |
4.66 | 16487989 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.37 | 1851702 |
MESH:D004487 |
Edema |
|
Arachidonic Acid |
7.92 | 15177302 7990266 16716910 9599246 11698051 9831321 |
MESH:D004487 |
Edema |
|
resveratrol |
7.92 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.92 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.49 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.49 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
27-hydroxycholesterol |
21.48 | 17410599 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
21.48 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
21.48 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
21.48 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
21.48 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
3.97 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
17.91 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
17.91 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
17.91 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
17.91 | 17893378 19155303 16202921 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
17.91 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
6.81 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
6.81 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.42 | 18037988 |
MESH:D004751 |
Enteritis |
|
lansoprazole |
5.47 | 16328016 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.14 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Astemizole |
7.17 | 1355641 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
7.17 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.45 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.18 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.51 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
2.97 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.59 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.34 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.38 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
5.95 | 17638652 15173087 16481741 16785472 16337965 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
5.95 | 16481741 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
5.95 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
6.95 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
6.95 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
22.30 | 16045604 15959796 16239168 12631006 19224547 12795759 61145 17595544 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
22.30 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
22.30 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
22.30 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
22.30 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
22.30 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
6.58 | 15751030 16513791 16534752 16611131 16002989 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
6.58 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.75 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.15 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.44 | 8888407 18558336 |
MESH:D005334 |
Fever |
|
Arachidonic Acid |
4.02 | 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.80 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
9.03 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
9.03 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
20.31 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
20.31 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Emodin |
20.31 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
20.31 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
20.31 | 17994277 |
MESH:D005393 |
Fish Diseases |
|
Albendazole |
5.30 | 12113305 |
MESH:D005499 |
Folliculitis |
|
Astemizole |
5.18 | 1671328 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
4.82 | 6392382 |
MESH:D057180 |
Frontotemporal Dementia |
marker/mechanism |
|
| |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
8.71 | 16983495 |
MESH:D005756 |
Gastritis |
|
Zinc |
8.71 | 17241300 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.22 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.49 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
12.85 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
12.85 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Okadaic Acid |
12.85 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
12.85 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.53 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
4.79 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.85 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.32 | 15172196 11014644 16376943 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.45 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
9.92 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
9.92 | 15162350 15102660 18337622 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
9.92 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.42 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
8.74 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
8.74 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
8.74 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
2.95 | 16495754 16244371 18006777 16330681 16879835 17888722 17875725 16707910 16244372 12587719 14766674 18674790 16144979 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
5.81 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Zinc |
5.81 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.03 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Malondialdehyde |
8.95 | 17278206 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
8.95 | 17241300 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.25 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.69 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.58 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.68 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
4.79 | 14986274 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
7.54 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
cypermethrin |
7.54 | 16487989 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
3.98 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.20 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.29 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.46 | 16876885 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.00 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
5.68 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
5.68 | 17606976 15147373 18501091 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.02 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.14 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.30 | 15340226 16354765 18606429 16959395 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
5.67 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
5.67 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.80 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
27-hydroxycholesterol |
7.62 | 17873880 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
7.62 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.86 | 16778211 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
3.81 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.36 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.73 | 12960047 14722030 |
MESH:D006973 |
Hypertension |
|
Arsenic |
6.57 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
6.57 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
6.57 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.38 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.66 | 17488730 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
4.82 | 16093927 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
8.89 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
8.89 | 16569931 16945680 |
MESH:D007022 |
Hypotension |
|
Dopamine |
4.35 | 6740701 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.59 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
9.13 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
9.13 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.66 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.79 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
8.37 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
8.37 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
8.37 | 11514358 |
MESH:D007249 |
Inflammation |
|
Aluminum |
17.58 | 16052892 |
MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
17.58 | 17371808 15177302 9831321 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
17.58 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
17.58 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
17.58 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
17.58 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
17.58 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
3.81 | 16624496 |
MESH:D007299 |
Insect Bites and Stings |
|
cypermethrin |
5.24 | 15189238 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.46 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.06 | 17994277 |
MESH:D007511 |
Ischemia |
|
Zinc |
3.92 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
7.75 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
7.75 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.70 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.26 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
17.81 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Acrolein |
17.81 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
17.81 | 10903974 18776723 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
17.81 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
17.81 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
17.81 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
13.24 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Malondialdehyde |
13.24 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
13.24 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
16.97 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
16.97 | 15003126 14681315 16762066 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
16.97 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
16.97 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
16.97 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Colchicine |
7.92 | 11749816 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
7.92 | 17184923 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
8.22 | 19148494 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
8.22 | 10602166 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
8.22 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.42 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.13 | 17008537 17658394 17802794 18587576 17296974 18172266 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Emodin |
4.37 | 17077332 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.53 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
7.61 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
7.61 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
5.08 | 17596541 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.08 | 17596541 19850784 16294345 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
5.08 | 16294345 17596541 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
4.51 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
9.84 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
9.84 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
9.84 | 17712046 17217047 17649720 16140955 19642359 19035177 9834237 12679006 19075265 17368321 16891316 17506722 16788101 19225113 16823087 16331271 17294898 16766008 17339181 16935935 17361223 17301526 17107899 15748426 19029980 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.24 | 10052129 11830472 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.30 | 16707609 |
MESH:D017513 |
Lichen Nitidus |
|
Astemizole |
5.72 | 2563723 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.76 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.61 | 15342952 17567588 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.14 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.10 | 16239168 21278145 16943688 11903743 11408273 17174718 17157831 16221502 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.10 | 20032147 18407596 18665156 18522880 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
8.75 | 12667390 18412020 10355542 12546737 15893842 15370692 17525996 14748882 17631135 16136751 17708605 17481882 18339082 15925388 15123356 20821823 17900296 17823541 15650968 17714472 12632512 17698563 13678700 12898905 18205269 17805973 16097048 18277467 17721639 18395914 18279442 16638106 12741479 18006644 15959796 14716496 12958196 11481614 17565644 12666154 15362042 17944888 15052691 12649538 18187930 17922224 16192424 17869086 18156304 15931870 15996030 18054572 18429990 18376398 12586293 16015684 17766677 16248980 16027843 14724832 16116963 15818738 16011737 14512876 12445421 18210741 17976157 14620537 17640975 18472332 18317297 18472094 18263696 18705752 15876570 12632514 18418968 17761835 16033810 15057751 12609069 17557913 18395095 12445418 18420326 12389079 18481824 15673190 14716833 18251166 18166357 15338365 15730626 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.75 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Emodin |
8.75 | 15288473 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.75 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.75 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.75 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.75 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
9.76 | 19784758 12587719 19460945 16610002 19014921 11587558 12969438 16611625 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
9.76 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
9.76 | 17285989 16964402 15830285 16246199 15720792 |
MESH:D008107 |
Liver Diseases |
|
cypermethrin |
9.76 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
9.76 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.45 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
7.28 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
7.28 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
26.75 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
26.75 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
26.75 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
26.75 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
26.75 | 18648771 19850985 19499222 21071580 12112319 19255062 19294768 18978307 12771043 20118626 18977376 16942905 18644402 20501860 19426721 19642983 19690152 9163691 19833225 15885732 21278145 20101389 20137499 2862719 19812893 15175105 20452335 20583210 19638242 19427195 18754104 19090486 19073162 19996281 21047994 21167192 20492335 10737359 20405173 2422723 19256749 19254457 19551842 20434301 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
26.75 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
26.75 | 18383874 17045692 16603448 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
26.75 | 19073162 19812893 20405173 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
26.75 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
26.75 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
16.96 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
16.96 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
16.96 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
16.96 | 19519916 16267830 9362446 19539802 21159647 18544905 17174075 18079962 19004024 18093689 18308698 18775883 17942915 19009564 18253720 3124819 16842330 18164116 18282651 2563599 17854601 19126423 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
16.96 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
16.96 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Astemizole |
4.02 | 18472280 11989578 |
MESH:D008171 |
Lung Diseases |
|
Acrolein |
13.47 | 11504702 |
MESH:D008171 |
Lung Diseases |
|
Aluminum |
13.47 | 16052892 |
MESH:D008171 |
Lung Diseases |
|
Asbestos, Serpentine |
13.47 | 17200189 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
13.47 | 8266340 19066396 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.52 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.15 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
14.76 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
14.76 | 17306315 19168569 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Asbestos, Serpentine |
14.76 | 11198217 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
14.76 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
14.76 | 20970405 20512841 21163286 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
14.76 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
14.76 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
14.76 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
14.76 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
14.76 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.06 | 15086387 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.42 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
9.51 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
9.51 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
9.51 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
8.23 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
8.23 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
15.75 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
15.75 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
15.75 | 14749477 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
15.75 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
3.86 | 15621674 |
MESH:D008288 |
Malaria |
|
Astemizole |
4.21 | 16816845 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.77 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
7.60 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.60 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
20.77 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
20.77 | 11807958 16891317 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
20.77 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
20.77 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
20.77 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
20.77 | 19196723 14580682 19196722 11731420 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
20.77 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.19 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.19 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.44 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.98 | 16827129 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
9.98 | 16270382 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
9.98 | 12025231 16342250 12040289 |
MESH:D008545 |
Melanoma |
|
resveratrol |
9.98 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
9.98 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.98 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.46 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
14.39 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
14.39 | 10803710 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
14.39 | 16388313 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.71 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.71 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.72 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.05 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.36 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.65 | 18765137 18803445 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.84 | 15792986 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
5.34 | 19299654 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
7.02 | 16274795 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
7.02 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.06 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
9.17 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
9.17 | 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
9.17 | 17164350 17049120 16267019 16490592 14749477 17935668 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Aluminum |
5.63 | 17086897 |
MESH:D020529 |
Multiple Sclerosis, Relapsing-Remitting |
|
Aluminum |
5.63 | 17086897 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.14 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.37 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
9.71 | 17596541 19805378 17611569 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
9.71 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
9.71 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
7.60 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
7.60 | 16288908 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
7.60 | 16525036 16317513 17188708 17125593 16456233 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
11.87 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
11.87 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
11.87 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
2.70 | 16810080 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.03 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
10.66 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
10.66 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
10.66 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
10.66 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.22 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Acrolein |
14.38 | 17329238 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
14.38 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
14.38 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
14.38 | 15958647 17353921 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
14.38 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
14.38 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
Asbestos, Serpentine |
7.32 | 11704859 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.32 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.26 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.01 | 17289903 |
MESH:D009393 |
Nephritis |
|
Acrolein |
5.55 | 12653641 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.06 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.70 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
7.22 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
7.22 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.31 | 18619942 15790535 17356569 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
17.80 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
17.80 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
17.80 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
17.80 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
9.22 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
9.22 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
9.22 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
5.77 | 8761367 15176712 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
5.77 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
15.17 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
15.17 | 11342003 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
15.17 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
15.17 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.16 | 12837982 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
8.46 | 17056641 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
8.46 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.38 | 20387270 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
4.95 | 16303764 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
2.91 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
3.66 | 8291058 |
MESH:D009759 |
Nystagmus, Pathologic |
|
Astemizole |
5.72 | 6135121 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
3.99 | 16517039 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.25 | 15867366 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.58 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.52 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
14.95 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.95 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
14.95 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
14.95 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
14.95 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
14.95 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
11.27 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
11.27 | 18093676 12161096 |
MESH:D010146 |
Pain |
|
Morphine |
11.27 | 16273134 6776300 20225289 18699797 15275824 15215642 |
MESH:D010146 |
Pain |
|
Tretinoin |
11.27 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
12.80 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
12.80 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
12.80 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
12.80 | 19003803 16929163 16500647 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
12.80 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.01 | 11578682 |
OMIM:260540 |
PARKINSON-DEMENTIA SYNDROME |
marker/mechanism |
|
| |
MESH:D010300 |
Parkinson Disease |
marker/mechanism |
|
| 20711177 19915575 |
MESH:D010300 |
Parkinson Disease |
|
Acrolein |
4.75 | 17690948 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
4.75 | 19114014 19232380 11535288 18191903 11445065 18619942 16412576 16140633 15451049 |
MESH:D020734 |
Parkinsonian Disorders |
marker/mechanism |
|
| |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.44 | 18197244 15927086 15795934 15574749 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.51 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
3.49 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.26 | 16905509 6392382 15371236 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.43 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
5.00 | 11550810 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.42 | 17983394 |
MESH:D020774 |
Pick Disease of the Brain |
marker/mechanism |
|
| |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.43 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
3.96 | 16977796 15687265 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Serpentine |
4.98 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.42 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.67 | 18007984 18929643 18381685 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.87 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
6.87 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
6.87 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
6.73 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Daunorubicin |
6.73 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.59 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
17.35 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
17.35 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
17.35 | 11118676 11399792 11896295 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
17.35 | 20603192 |
MESH:D011317 |
Priapism |
|
Methylene Blue |
6.49 | 9542685 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.22 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
5.01 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
5.01 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
5.01 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
5.01 | 15846301 17136230 15046698 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
5.01 | 15749863 16729912 16868541 16888761 15897917 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
5.01 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
5.01 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
5.01 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
5.01 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
5.01 | 16356831 17172428 17136230 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
5.01 | 15767336 17636462 17718901 17804756 17675339 16731767 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
5.01 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
5.01 | 12429649 16606632 16517595 16700911 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
7.05 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
7.05 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.60 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
3.80 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.92 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.06 | 16723453 |
MESH:D011649 |
Pulmonary Alveolar Proteinosis |
|
27-hydroxycholesterol |
5.65 | 15466366 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Serpentine |
5.19 | 18569384 15511213 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
5.19 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.39 | 15538739 16160472 18722050 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
8.25 | 12732208 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
8.25 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.84 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
Morphine |
5.83 | 19211983 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.83 | 16314181 17520802 17058453 16317513 15827377 |
MESH:D012131 |
Respiratory Insufficiency |
marker/mechanism |
|
| |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
7.50 | 16303925 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
7.50 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
8.62 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
8.62 | 19155313 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Astemizole |
4.69 | 10822083 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.54 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.35 | 16767912 17710206 15625365 15675481 17203757 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.55 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.06 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
1.95 | 15737665 19110320 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.15 | 16636934 |
MESH:D012640 |
Seizures |
|
Lithium |
4.76 | 19660546 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
4.76 | 11738929 14763951 15475178 3137016 17978042 1511512 11044598 16876388 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.51 | 16759981 15952646 17548696 16353154 6392382 17938729 17050553 17453740 18709164 19834688 16702368 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
21.01 | 15504454 17050553 17029826 16251483 19538983 17976673 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
21.01 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
21.01 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Okadaic Acid |
21.01 | 12628509 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
21.01 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
21.01 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
21.01 | 16467112 |
MESH:D019082 |
Smith-Lemli-Opitz Syndrome |
|
27-hydroxycholesterol |
5.30 | 11254748 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.86 | 16767912 17203757 15625365 |
OMIM:270800 |
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE |
|
27-hydroxycholesterol |
5.64 | 19812052 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
15.87 | 16709447 16002989 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
15.87 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
15.87 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
4.79 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
8.46 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
8.46 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.20 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
10.21 | 19951488 19570321 19430551 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
10.21 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.85 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.85 | 17172411 16424979 19084572 18396642 17498489 17522103 18567086 15786421 16951190 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
3.85 | 18506536 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.85 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
lansoprazole |
4.43 | 17918041 18726076 11906479 18087811 17895592 |
MESH:D020521 |
Stroke |
|
Acrolein |
3.97 | 16269634 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.84 | 16321402 |
MESH:D013494 |
Supranuclear Palsy, Progressive |
marker/mechanism |
|
| |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.33 | 12837982 |
MESH:D024801 |
Tauopathies |
marker/mechanism |
|
| |
MESH:D024801 |
Tauopathies |
|
Albendazole |
28.26 | 16930453 |
MESH:D024801 |
Tauopathies |
|
Camptothecin |
28.26 | 16930453 |
MESH:D024801 |
Tauopathies |
|
Daunorubicin |
28.26 | 16930453 |
MESH:D024801 |
Tauopathies |
|
Methylene Blue |
28.26 | 16930453 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
28.26 | 16930453 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.94 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.53 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.16 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
8.70 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
8.70 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
8.70 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.94 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
18.41 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
18.41 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
18.41 | 16051514 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
18.41 | 16543248 |
MESH:D016171 |
Torsades de Pointes |
|
Astemizole |
4.49 | 9583453 8256756 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.49 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.73 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
3.79 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
15.30 | 11144890 15987713 19429237 17306315 19322015 18640142 17976673 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
15.30 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
15.30 | 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
15.30 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
15.30 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
15.30 | 16712894 17572228 8653321 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
3.93 | 8888407 |
MESH:D014570 |
Urologic Diseases |
|
cypermethrin |
5.13 | 16487989 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
6.81 | 10982225 |
MESH:D014581 |
Urticaria |
|
Astemizole |
6.81 | 2859714 2147912 2883202 1976298 3097109 2565098 2568013 3080510 2568189 1683191 2885854 3134034 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
22.91 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
22.91 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
22.91 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
22.91 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
22.91 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.43 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
12.09 | 16690809 15809267 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
12.09 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
12.09 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.87 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.24 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.73 | 16513791 16002989 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.01 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.85 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.88 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
7.99 | 17678736 17638931 17334414 16364871 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
7.99 | 17488730 |
MESH:D014717 |
Vertigo |
|
Astemizole |
5.72 | 3105558 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.36 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.51 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.34 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.70 | 17120751 |